Safety, tolerability, and preliminary activity of CUDC-907, a first-in-class, oral, dual inhibitor of HDAC and PI3K, in patients with relapsed or refractory lymphoma or multiple my... von Younes, Anas, Dr, Berdeja, Jesus G, MD, Patel, Manish R, MD, Flinn, Ian, MD, Gerecitano, John F, MD, Neelapu, Sattva S, MD, Kelly, Kevin R, MD, Copeland, Amanda R, MSN, Akins, Amy, BSN, Clancy, Myles S, MBA, Gong, Lucy, PharmD, Wang, Jing, PhD, Ma, Anna, MS, Viner, Jaye L, MD, Oki, Yasuhiro, MD

Volltext

Mocetinostat for relapsed classical Hodgkin's lymphoma: an open-label, single-arm, phase 2 trial von Younes, Anas, Prof, Oki, Yasuhiro, MD, Bociek, R Gregory, MD, Kuruvilla, John, MD, Fanale, Michelle, MD, Neelapu, Sattva, MD, Copeland, Amanda, RN, Buglio, Daniela, MD, Galal, Ahmed, MD, Besterman, Jeffrey, PhD, Li, Zuomei, PhD, Drouin, Michel, MD, Patterson, Tracy, RN, Ward, M Renee, MD, Paulus, Jessica K, ScD, Ji, Yuan, PhD, Medeiros, L Jeffrey, Prof, Martell, Robert E, MD

Volltext

Phase I Multidose-Escalation Study of the Anti-CD19 Maytansinoid Immunoconjugate SAR3419 Administered by Intravenous Infusion Every 3 Weeks to Patients With Relapsed/Refractory B-C... von Younes, Anas, Kim, Stella, Romaguera, Jorge, Copeland, Amanda, Farial, Silvana de Castro, Kwak, Larry W, Fayad, Luis, Hagemeister, Frederick, Fanale, Michelle, Neelapu, Sattva, Lambert, John M, Morariu-Zamfir, Rodica, Payrard, Sandrine, Gordon, Leo I

Volltext

Phase I Study of a Novel Oral Janus Kinase 2 Inhibitor, SB1518, in Patients With Relapsed Lymphoma: Evidence of Clinical and Biologic Activity in Multiple Lymphoma Subtypes von Younes, Anas, Romaguera, Jorge, Fanale, Michelle, McLaughlin, Peter, Hagemeister, Frederick, Copeland, Amanda, Neelapu, Sattva, Kwak, Larry, Shah, Jatin, de Castro Faria, Silvana, Hart, Stefan, Wood, Jeanette, Jayaraman, Ramesh, Ethirajulu, Kantharaj, Zhu, Joy

Volltext

ENGAGE- 501: phase II study of entinostat (SNDX-275) in relapsed and refractory Hodgkin lymphoma von Batlevi, Connie Lee, Kasamon, Yvette, Bociek, R Gregory, Lee, Peter, Gore, Lia, Copeland, Amanda, Sorensen, Rachel, Ordentlich, Peter, Cruickshank, Scott, Kunkel, Lori, Buglio, Daniela, Hernandez-Ilizaliturri, Francisco, Younes, Anas

Volltext

Evaluation of US oncology electronic health record real-world data to reduce uncertainty in health technology appraisals: a retrospective cohort study von Mpofu, Philani, Kent, Seamus, Jónsson, Páll, Pittell, Harlan, Groves, Brad, Altomare, Ivy, Copeland, Amanda, Baxi, Shrujal, Bargo, Danielle, Sujenthiran, Arun, Adamson, Blythe

Volltext

Phase 2 study of rituximab plus ABVD in patients with newly diagnosed classical Hodgkin lymphoma von Younes, Anas, Oki, Yasuhiro, McLaughlin, Peter, Copeland, Amanda R., Goy, Andre, Pro, Barbara, Feng, Lei, Yuan, Ying, Chuang, Hubert H., Macapinlac, Homer A., Hagemeister, Fredrick, Romaguera, Jorge, Samaniego, Felipe, Fanale, Michelle A., Dabaja, Bouthaina Shbib, Rodriguez, Maria A., Dang, Nam, Kwak, Larry W., Neelapu, Sattva S., Fayad, Luis E.

Volltext

Phase II Study of Yttrium-90–Ibritumomab Tiuxetan in Patients With Relapsed or Refractory Mantle Cell Lymphoma von WANG, Michael, OKI, Yasuhiro, SAMUELS, Barry I, LOYER, Evelyne M, YUAN JI, YOUNES, Anas, PRO, Barbara, ENRIQUE ROMAGUERA, Jorge, ALMA RODRIGUEZ, Maria, SAMANIEGO, Felipe, MCLAUGHLIN, Peter, HAGEMEISTER, Frederick, NEELAPU, Sattva, COPELAND, Amanda

Volltext

Integrated DNA/RNA targeted genomic profiling of diffuse large B-cell lymphoma using a clinical assay von Intlekofer, Andrew M., Joffe, Erel, Batlevi, Connie L., Hilden, Patrick, He, Jie, Seshan, Venkatraman E., Zelenetz, Andrew D., Palomba, M. Lia, Moskowitz, Craig H., Portlock, Carol, Straus, David J., Noy, Ariela, Horwitz, Steven M., Gerecitano, John F., Moskowitz, Alison, Hamlin, Paul, Matasar, Matthew J, Kumar, Anita, van den Brink, Marcel R., Knapp, Kristina M., Pichardo, Janine D., Nahas, Michelle K., Trabucco, Sally E., Mughal, Tariq, Copeland, Amanda R., Papaemmanuil, Elli, Moarii, Mathai, Levine, Ross L., Dogan, Ahmet, Miller, Vincent A., Younes, Anas

Volltext

Alcohol-Based Handrub Formulated Developed Specifically for High-use Environments Can Improve Key Skin Condition Measures While Maintaining Aesthetics and Antimicrobial Efficacy von Copeland, Amanda J, Cartner, Todd, Edmonds, Sarah L., MS, Tian, Kegui

Volltext

Phase II Study of an AKT Inhibitor MK2206 in Patients with Relapsed or Refractory Lymphoma von Oki, Yasuhiro, Fanale, Michelle A., Romaguera, Jorge E., Fayad, Luis, Fowler, Nathan, Copeland, Amanda R.M., Samaniego, Felipe, Kwak, Larry W., Neelapu, Sattva S, Wang, Michael, Feng, Lei, Younes, Anas

Volltext

Identification of Actionable Genomic Alterations Across Different Lymphoma Histologies Using a Comprehensive Next Generation Genomic Sequencing Clinical Assay von Batlevi, Connie, Moskowitz, Craig H., Zelenetz, Andrew D., Horwitz, Steven M., Palomba, Lia, Gerecitano, John F., Copeland, Amanda R.M., Hamlin, Paul, Matasar, Matthew J., Sauter, Craig S., Moskowitz, Alison J, Noy, Ariela, Straus, David J., Portlock, Carol S, Mazzei, Colleen, Pichardo, Janine D., Miller, Vincent, Stephens, Phil J, He, Jie, Feldstein, Julie T, Levine, Ross L., Dogan, Ahmet, Younes, Anas

Volltext

Profiling Genomic Alterations Of Diffuse Large B-Cell Lymphoma (DLBCL) At Diagnosis, Relapse, and Transformation, Using a Novel Clinical Diagnostic Targeted Sequencing Platform von Intlekofer, Andrew M., Sheshan, Venkatraman E., Levine, Ross L., Zelenetz, Andrew D., Teruya-Feldstein, Julie, Dogan, Ahmet, Palomba, Maria Lia, Moskowitz, Craig H., van den Brink, Marcel R.M., Knapp, Kristina M., Copeland, Amanda R.M., Pichardo, Janine D., Brennan, Kristina W., Young, Geneva, He, Jie, Nahas, Michelle K., Yelensky, Roman, Otto, Geoff A., Lipson, Doron, Stephens, Philip J., Miller, Vincent A., Younes, Anas

Volltext

Current treatment strategies in Hodgkin lymphomas von Copeland, Amanda, Younes, Anas

Volltext

Novel Non-Antimicrobial Soap Developed to Improve Skin Cleansing for Healthcare von Copeland, Amanda, Cartner, Todd J., Rulison, Christopher

Volltext

ADS-61 - Novel Non-Antimicrobial Soap Developed to Improve Skin Cleansing for Healthcare von Copeland, Amanda, Cartner, Todd J., Rulison, Christopher

Volltext

Phase II study of an AKT inhibitor MK2206 in patients with relapsed or refractory lymphoma von Oki, Yasuhiro, Fanale, Michelle, Romaguera, Jorge, Fayad, Luis, Fowler, Nathan, Copeland, Amanda, Samaniego, Felipe, Kwak, Larry W., Neelapu, Sattva, Wang, Michael, Feng, Lei, Younes, Anas

Volltext

A phase 2 study of mocetinostat, a histone deacetylase inhibitor, in relapsed or refractory lymphoma von Batlevi, Connie L., Crump, Michael, Andreadis, Charalambos, Rizzieri, David, Assouline, Sarit E., Fox, Susan, Jagt, Richard H. C., Copeland, Amanda, Potvin, Diane, Chao, Richard, Younes, Anas

Volltext

Experience with obatoclax mesylate (GX15-070), a small molecule pan–Bcl-2 family antagonist in patients with relapsed or refractory classical Hodgkin lymphoma von Oki, Yasuhiro, Copeland, Amanda, Hagemeister, Fredrick, Fayad, Luis E., Fanale, Michelle, Romaguera, Jorge, Younes, Anas

Volltext

Phase I Study of Panobinostat plus Everolimus in Patients with Relapsed or Refractory Lymphoma von OKI, Yasuhiro, BUGLIO, Daniela, FOWLER, Nathan, HAGEMEISTER, Fredrick, JIEXIN ZHANG, SHOUHAO ZHOU, LEI FENG, YOUNES, Anas, FANALE, Michelle, FAYAD, Luis, COPELAND, Amanda, ROMAGUERA, Jorge, KWAK, Larry W, PRO, Barbara, DE CASTRO FARIA, Silvana, NEELAPU, Sattva

Volltext